Literature DB >> 23487421

Divergent effects of T cell costimulation and inflammatory cytokine production on autoimmune peripheral neuropathy provoked by Aire deficiency.

Xiaopei L Zeng1, Anil Nagavalli, Colin-Jamal Smith, James F Howard, Maureen A Su.   

Abstract

Chronic inflammatory demyelinating polyneuropathy results from autoimmune destruction of the peripheral nervous system and is a component of the multiorgan autoimmunity syndrome that results from Aire gene mutations in humans. In parallel, peripheral nervous system autoimmunity resembling chronic inflammatory demyelinating polyneuropathy develops spontaneously in NOD mice with a partial loss of Aire function (NOD.Aire(GW/+) mice) and is a T cell-mediated disease. In this study, we analyze how key aspects of T cell activation and function modulate disease development in Aire-deficient mice. We show that genetic ablation of the Th1 cytokine IFN-γ completely prevents clinical and electrophysiological evidence of neuropathy in NOD.Aire(GW/+) mice. IFN-γ deficiency is associated with absence of immune infiltration and decreased expression of the T cell chemoattractant IP-10 in sciatic nerves. Thus, IFN-γ is absolutely required for the development of autoimmune peripheral neuropathy in NOD.Aire(GW/+) mice. Because IFN-γ secretion is enhanced by B7-CD28 costimulation of T cells, we sought to determine the effects of these costimulatory molecules on neuropathy development. Surprisingly, B7-2 deficiency accelerated neuropathy development in NOD.Aire(GW/+) mice, and Ab blockade of both B7-1 and B7-2 resulted in fulminant, early-onset neuropathy. Thus, in contrast to IFN-γ, B7-2 alone and B7-1/B7-2 in combination function to ameliorate neuropathy development in NOD.Aire(GW/+) mice. Together, these findings reveal distinct and opposing effects of the T cell costimulatory pathway and IFN-γ production on the pathogenesis of autoimmune peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23487421      PMCID: PMC3622123          DOI: 10.4049/jimmunol.1203001

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production.

Authors:  Hilde Kelchtermans; Sofie Struyf; Bert De Klerck; Tania Mitera; Marijke Alen; Lies Geboes; Maarten Van Balen; Chris Dillen; Willy Put; Conny Gysemans; Alfons Billiau; Jo Van Damme; Patrick Matthys
Journal:  J Leukoc Biol       Date:  2007-01-02       Impact factor: 4.962

2.  Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy.

Authors:  Hye-Jung Kim; Cha-Gyun Jung; Mark A Jensen; Danuta Dukala; Betty Soliven
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 3.  Interstitial leukocyte migration and immune function.

Authors:  Peter Friedl; Bettina Weigelin
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

Review 4.  Cytotoxic T cells.

Authors:  Mads Hald Andersen; David Schrama; Per Thor Straten; Jürgen C Becker
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

5.  Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance.

Authors:  Anthony K Shum; Jason DeVoss; Catherine L Tan; Yafei Hou; Kellsey Johannes; Clodagh S O'Gorman; Kirk D Jones; Etienne B Sochett; Lawrence Fong; Mark S Anderson
Journal:  Sci Transl Med       Date:  2009-12-02       Impact factor: 17.956

6.  Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data.

Authors:  Robin H Xia; Nejla Yosef; Eroboghene E Ubogu
Journal:  Muscle Nerve       Date:  2010-06       Impact factor: 3.217

7.  Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.

Authors:  Hélène Bour-Jordan; Heather L Thompson; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

8.  Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire.

Authors:  Maureen A Su; Karen Giang; Kristina Zumer; Huimin Jiang; Irena Oven; John L Rinn; Jason J Devoss; Kellsey P A Johannes; Wen Lu; James Gardner; Angela Chang; Paula Bubulya; Howard Y Chang; B Matija Peterlin; Mark S Anderson
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 9.  Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes; David Allen; Anna Makowska; Norman A Gregson
Journal:  J Peripher Nerv Syst       Date:  2006-03       Impact factor: 3.494

10.  Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy.

Authors:  Mariella Valenzise; Antonella Meloni; Corrado Betterle; Bruno Giometto; Massimo Autunno; Anna Mazzeo; Antonio Cao; Filippo De Luca
Journal:  Eur J Pediatr       Date:  2008-05-07       Impact factor: 3.183

View more
  10 in total

1.  IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.

Authors:  Collin-Jamal Smith; Denise E Allard; Yan Wang; James F Howard; Stephanie A Montgomery; Maureen A Su
Journal:  J Immunol       Date:  2018-01-24       Impact factor: 5.422

Review 2.  Animal models of autoimmune neuropathy.

Authors:  Betty Soliven
Journal:  ILAR J       Date:  2014

Review 3.  The NOD Mouse Beyond Autoimmune Diabetes.

Authors:  Anne-Marie Aubin; Félix Lombard-Vadnais; Roxanne Collin; Holly A Aliesky; Sandra M McLachlan; Sylvie Lesage
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

4.  Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.

Authors:  Denise E Allard; Yan Wang; Jian Joel Li; Bridget Conley; Erin W Xu; David Sailer; Caellaigh Kimpston; Rebecca Notini; Collin-Jamal Smith; Emel Koseoglu; Joshua Starmer; Xiaopei L Zeng; James F Howard; Ahmet Hoke; Steven S Scherer; Maureen A Su
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

Review 5.  Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.

Authors:  Richard J Bright; Jenny Wilkinson; Brendon J Coventry
Journal:  BMC Neurol       Date:  2014-02-07       Impact factor: 2.474

6.  Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.

Authors:  Hélène Bour-Jordan; Heather L Thompson; Jennifer R Giampaolo; Dan Davini; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  J Autoimmun       Date:  2013-07-12       Impact factor: 7.094

Review 7.  Novel pathomechanisms in inflammatory neuropathies.

Authors:  David Schafflick; Bernd C Kieseier; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  J Neuroinflammation       Date:  2017-11-28       Impact factor: 8.322

8.  Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.

Authors:  Feeling Y Chen; Albert Lee; Shaokui Ge; Sara Nathan; Sarah M Knox; Nancy A McNamara
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

9.  Systemic IGF-1 gene delivery by rAAV9 improves spontaneous autoimmune peripheral polyneuropathy (SAPP).

Authors:  Tong Gao; Nataliia Bogdanova; Sameera Ghauri; Gang Zhang; Jianxin Lin; Kazim Sheikh
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

10.  Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity.

Authors:  Yan Wang; Lily Guo; Xihui Yin; Ethan C McCarthy; Mandy I Cheng; Aline T Hoang; Ho-Chung Chen; Anushi Y Patel; Denise Allard Trout; Erin Xu; Natalie Yakobian; Willy Hugo; James F Howard; Katherine M Sheu; Alexander Hoffmann; Melissa G Lechner; Maureen A Su
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.